Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Razan Mohty

Showing results (31-40 of 48) with videos related to

Pageof 5
Sort By:
Mucosal Immunology|July 20, 2021
Impact of gut fungal and bacterial communities on the outcome of allogeneic hematopoietic cell transplantationFlorent Malard, Aonghus Lavelle, Giorgia Battipaglia, et al.
Current Research in Translational Medicine|May 25, 2026
Efficacy of bispecific T-cell engagers after CAR T-cell therapy failure in aggressive large B-cell lymphomaMohamed A Kharfan-Dabaja, Tea Reljic, Sarah Abdel-Razeq, et al.
European Journal of Haematology|April 9, 2019
Impact of cyclosporine A concentration on acute graft-vs-host disease incidence after haploidentical hematopoietic cell transplantationNicolas Stocker, Remy Duléry, Giorgia Battipaglia, et al.
Cancer Reports (Hoboken, N.J.)|November 20, 2024
Outcomes of Cancer Patients Affected by COVID-19 in Different Settings: A Retrospective Study in LebanonAhmad El Mahmoud, Elie Jean Karam, Reine Abou Zeidane, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 28, 2020
Impact of Adding Antithymocyte Globulin to Posttransplantation Cyclophosphamide in Haploidentical Stem-Cell TransplantationJean El-Cheikh, Raynier Devillier, Remy Dulery, et al.
Transplantation and Cellular Therapy|July 16, 2022
Impact of Rituximab and Corticosteroids on Late Cytopenias Post-Chimeric Antigen Receptor T Cell TherapyMadiha Iqbal, Radhika Bansal, Farah Yassine, et al.
Blood Advances|January 5, 2024
Applying the EHA/EBMT grading for ICAHT after CAR-T: comparative incidence and association with infections and mortalityKai Rejeski, Yucai Wang, Doris K Hansen, et al.
Hematology/Oncology and Stem Cell Therapy|June 26, 2023
Post-Autologous Hematopoietic Cell Transplant Care in the "Home Sweet Home" Setting: A Treatment Paradigm ShiftMohamed A Kharfan-Dabaja, Vivek Roy, Hemant Murthy, et al.
Bone Marrow Transplantation|November 2, 2019
Thiotepa and antithymocyte globulin-based conditioning prior to haploidentical transplantation with posttransplant cyclophosphamide in high-risk hematological malignanciesZinaida Peric, Razan Mohty, Juliana Bastos, et al.
American Journal of Hematology|August 16, 2023
The CAR-HEMATOTOX score identifies patients at high risk for hematological toxicity, infectious complications, and poor treatment outcomes following brexucabtagene autoleucel for relapsed or refractory MCLKai Rejeski, Yucai Wang, Omar Albanyan, et al.
Pageof 5

Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
Mucosal Immunology|July 20, 2021
Impact of gut fungal and bacterial communities on the outcome of allogeneic hematopoietic cell transplantationFlorent Malard, Aonghus Lavelle, Giorgia Battipaglia, et al.
Current Research in Translational Medicine|May 25, 2026
Efficacy of bispecific T-cell engagers after CAR T-cell therapy failure in aggressive large B-cell lymphomaMohamed A Kharfan-Dabaja, Tea Reljic, Sarah Abdel-Razeq, et al.
European Journal of Haematology|April 9, 2019
Impact of cyclosporine A concentration on acute graft-vs-host disease incidence after haploidentical hematopoietic cell transplantationNicolas Stocker, Remy Duléry, Giorgia Battipaglia, et al.
Cancer Reports (Hoboken, N.J.)|November 20, 2024
Outcomes of Cancer Patients Affected by COVID-19 in Different Settings: A Retrospective Study in LebanonAhmad El Mahmoud, Elie Jean Karam, Reine Abou Zeidane, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 28, 2020
Impact of Adding Antithymocyte Globulin to Posttransplantation Cyclophosphamide in Haploidentical Stem-Cell TransplantationJean El-Cheikh, Raynier Devillier, Remy Dulery, et al.
Transplantation and Cellular Therapy|July 16, 2022
Impact of Rituximab and Corticosteroids on Late Cytopenias Post-Chimeric Antigen Receptor T Cell TherapyMadiha Iqbal, Radhika Bansal, Farah Yassine, et al.
Blood Advances|January 5, 2024
Applying the EHA/EBMT grading for ICAHT after CAR-T: comparative incidence and association with infections and mortalityKai Rejeski, Yucai Wang, Doris K Hansen, et al.
Hematology/Oncology and Stem Cell Therapy|June 26, 2023
Post-Autologous Hematopoietic Cell Transplant Care in the "Home Sweet Home" Setting: A Treatment Paradigm ShiftMohamed A Kharfan-Dabaja, Vivek Roy, Hemant Murthy, et al.
Bone Marrow Transplantation|November 2, 2019
Thiotepa and antithymocyte globulin-based conditioning prior to haploidentical transplantation with posttransplant cyclophosphamide in high-risk hematological malignanciesZinaida Peric, Razan Mohty, Juliana Bastos, et al.
American Journal of Hematology|August 16, 2023
The CAR-HEMATOTOX score identifies patients at high risk for hematological toxicity, infectious complications, and poor treatment outcomes following brexucabtagene autoleucel for relapsed or refractory MCLKai Rejeski, Yucai Wang, Omar Albanyan, et al.
Pageof 5